Found: 20
Select item for more details and to access through your institution.
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).
- Published in:
- International Journal of Neuropsychopharmacology, 2021, v. 24, n. 1, p. 22, doi. 10.1093/ijnp/pyaa068
- By:
- Publication type:
- Article
Bifactor Modeling of the Positive and Negative Syndrome Scale: Generalized Psychosis Spans Schizoaffective, Bipolar, and Schizophrenia Diagnoses.
- Published in:
- Schizophrenia Bulletin, 2018, v. 44, n. 6, p. 1204, doi. 10.1093/schbul/sbx163
- By:
- Publication type:
- Article
Assessing Medication Adherence and Healthcare Utilization and Cost Patterns Among Hospital-Discharged Patients with Schizoaffective Disorder.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 3, p. 335, doi. 10.1007/s40258-014-0095-8
- By:
- Publication type:
- Article
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality.
- Published in:
- BMC Psychiatry, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12888-023-05017-y
- By:
- Publication type:
- Article
A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 2857, doi. 10.2147/NDT.S417027
- By:
- Publication type:
- Article
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 693, doi. 10.2147/NDT.S391096
- By:
- Publication type:
- Article
Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials.
- Published in:
- Neuropsychiatric Disease & Treatment, 2021, v. 17, p. 2347, doi. 10.2147/NDT.S314874
- By:
- Publication type:
- Article
Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone.
- Published in:
- Brain & Behavior, 2023, v. 13, n. 8, p. 1, doi. 10.1002/brb3.3171
- By:
- Publication type:
- Article
Commentary on Cochrane review: "Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder".
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 8, p. 836, doi. 10.1177/02698811221123046
- By:
- Publication type:
- Article
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.
- Published in:
- CNS Drugs, 2023, v. 37, n. 8, p. 715, doi. 10.1007/s40263-023-01026-3
- By:
- Publication type:
- Article
Comparison of the Peak-to-trough Fluctuation in Plasma Concentration of Long-acting Injectable Antipsychotics and Their Oral Equivalents.
- Published in:
- Innovations in Clinical Neuroscience, 2012, v. 9, n. 7/8, p. 17
- By:
- Publication type:
- Article
Development and Psychometric Evaluation of a Clinical Global Impression for Schizoaffective Disorder Scale.
- Published in:
- Innovations in Clinical Neuroscience, 2012, v. 9, n. 1, p. 15
- By:
- Publication type:
- Article
Sequencing Double-Stranded DNA By Strand Displacement.
- Published in:
- Nucleic Acids Research, 1997, v. 25, n. 3, p. 677
- By:
- Publication type:
- Article
A new red alga preserved with possible reproductive bodies from the 518‐million‐year‐old Qingjiang biota.
- Published in:
- Journal of Systematics & Evolution, 2023, v. 61, n. 6, p. 1091, doi. 10.1111/jse.12942
- By:
- Publication type:
- Article
Geographical diversification of growth-defense strategies in an invasive plant.
- Published in:
- Journal of Systematics & Evolution, 2013, v. 51, n. 3, p. 308, doi. 10.1111/j.1759-6831.2012.00239.x
- By:
- Publication type:
- Article
Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00453-y
- By:
- Publication type:
- Article
Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00453-y
- By:
- Publication type:
- Article
A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II).
- Published in:
- Quality of Life Research, 2023, v. 32, n. 11, p. 3053, doi. 10.1007/s11136-023-03451-9
- By:
- Publication type:
- Article
Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double‐blind, placebo‐controlled study)
- Published in:
- Asia-Pacific Psychiatry, 2023, v. 15, n. 4, p. 1, doi. 10.1111/appy.12548
- By:
- Publication type:
- Article